↑Hacohen N, Kramer S, Sutherland D, Hiromi Y, Krasnow MA (Feb 1998). "sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways". Cell. 92 (2): 253–63. doi:10.1016/S0092-8674(00)80919-8. PMID9458049.
Lim J, Wong ES, Ong SH, et al. (2000). "Sprouty proteins are targeted to membrane ruffles upon growth factor receptor tyrosine kinase activation. Identification of a novel translocation domain". J. Biol. Chem. 275 (42): 32837–45. doi:10.1074/jbc.M002156200. PMID10887178.
Hanafusa H, Torii S, Yasunaga T, Nishida E (2004). "Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway". Nat. Cell Biol. 4 (11): 850–8. doi:10.1038/ncb867. PMID12402043.
Di Y, Li J, Zhang Y, et al. (2004). "HCC-associated protein HCAP1, a variant of GEMIN4, interacts with zinc-finger proteins". J. Biochem. 133 (6): 713–8. doi:10.1093/jb/mvg091. PMID12869526.
Wang L, Ji C, Wu H, et al. (2004). "Identification and expression analysis of a novel splice variant of human Sprouty1 gene". Int. J. Mol. Med. 12 (5): 783–7. doi:10.3892/ijmm.12.5.783. PMID14533010.
Anteby EY, Natanson-Yaron S, Greenfield C, et al. (2005). "Human placental Hofbauer cells express sprouty proteins: a possible modulating mechanism of villous branching". Placenta. 26 (6): 476–83. doi:10.1016/j.placenta.2004.08.008. PMID15950061.
Cabrita MA, Jäggi F, Widjaja SP, Christofori G (2006). "A functional interaction between sprouty proteins and caveolin-1". J. Biol. Chem. 281 (39): 29201–2912. doi:10.1074/jbc.M603921200. PMID16877379.
Fritzsche S, Kenzelmann M, Hoffmann MJ, et al. (2007). "Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma". Endocr. Relat. Cancer. 13 (3): 839–49. doi:10.1677/erc.1.01190. PMID16954433.
Schaaf G, Hamdi M, et al. (2010). "Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene". Cancer Research. 70 (2): 762–71. doi:10.1158/0008-5472.CAN-09-2532. PMID20068162.